Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2006-04-18
2006-04-18
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
C530S351000
Reexamination Certificate
active
07029664
ABSTRACT:
The present invention is to provide a chicken LIF gene. Based on this genetic information, LIF protein derived from the chicken can be stably supplied and it solves the problems of the creation of transgenic chickens in the past. In addition, the present invention provides not only transgenic chickens for testing purposes but also supplies the first practical transgenic stock animals. The present invention relates to leukemia inhibitory factor (LIF) shown in sequence No. 2, and the gene that encodes thereof shown in sequence No. 1, and a manufacturing method of chicken LIF. In addition, the present invention pertains to a differential preventer of the chicken differentiable cell, and a method of chicken differential prevention and a culturing method for the chicken differentiable cell using thereof, and a medium comprising thereof.
REFERENCES:
patent: 5418159 (1995-05-01), Gough et al.
patent: 5935813 (1999-08-01), Hillman et al.
patent: 08-154681 (1996-06-01), None
patent: WO-98/16630 (1998-04-01), None
patent: WO 00/08132 (2000-02-01), None
Mikayama et al. Proc. Natl. Acad. Sci. USA, vol. 90, pp. 10056-10060.
Voet et al. Biochemistry. John wiley & Sons, INc., pp. 126-128, and 228-234.
European Examination Report Dated Aug. 25, 2004.
Database EMBL (GSN); Cech, Tr. et al. “HTRTsequence specific antisense phosphorothioate oligonucleotide #41,” retrieved from EBI Database accesion No. AAZ08165, 1 page (Jan. 17, 2000).
Austin G. Smith et al., “ Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides”. vol. 336, pp. 688-691, Nature, (Dec. 1988).
Nicholas M. Gough et al., “Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor,” Proceedings of the National Academy of Sciences of USA, National Academy of Science. vol. 85, pp. 2623-2627 (Apr., 1988).
Z. Yang et al., “Use of Avian Cytokines in Mammalian Embryonic Stem Cell Culture,” Poultry Science, vol. 73, No. 7, pp. 965-974 (1994).
Helen Sang, “ Transgenic chickens-methods and potential applications,” Trends in Biotechnology, vol. 12, No. 10, pp. 415-420 (Oct., 1994).
B. Pain et al., “ Long-term in vitro culture and characterization of avian embryonic stem cells with multiple morphogenetic potentialities,” Development Company of Biologists, vol. 122, No. 8, pp. 2339-2348, The Company of Biologists Ltd. (1996).
F. A. Ponce de León et al., “Recent advances in chicken primordial germ cell technology,” Rev. Bras. Reprod. Anim., vol. 21, No. 3, pp. 96-101, Department of Animal Science, University of Minnesota (1997).
Tae Sub Park et al., “ Derivation and Characterization of Pluripotent Embryonic Germ Cells in Chicken,” Molecular Reproduction and Development, vol. 56, pp. 475-482, Wiley-Liss, Inc. (Aug. 2000).
Japan Office Action mailed Mar. 22, 2005 (1 page).
Yuko Kato et al. “Cloning and Sequence Analysis of the Bovine Leukemia Inhibitory Factor (LIF) Gene”, Amin. Sci. Technol., vol. 67, 1996, pages 135-141.
J.A. Piedrahita et al., “Genetic characterization of the bovine leukemia inhibitory factor (LIF) gene: isolation and sequencing, chromosome assignment and microsatellite analysis”, Anim. Genet., vol. 28, 1997, pages 14-20.
Furusawa Shuichi
Horiuchi Hiroyuki
Matsuda Haruo
Hiroshima University
Mertz Prema
Rader & Fishman & Grauer, PLLC
LandOfFree
Chicken leukemia inhibitory factor (LIF) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chicken leukemia inhibitory factor (LIF), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chicken leukemia inhibitory factor (LIF) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3583657